Temperature-sensitive gel preparation containing glutaminase inhibitor as well as preparation method and application of temperature-sensitive gel preparation
By using a thermosensitive gel formulation under photothermal signal, it first releases glutaminase inhibitors to regulate the metabolism of the tumor microenvironment, and then releases immune checkpoint inhibitors to activate T cells, thus solving the problem of immunosuppression in the tumor microenvironment and achieving highly efficient anti-tumor immunotherapy.
Patent Information
- Application Number
- CN202610058702.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-16
- Publication Date
- 2026-04-21
AI Technical Summary
In current tumor immunotherapy, immune checkpoint inhibitors are not very effective due to immunosuppression caused by abnormally active glutamine metabolism in the tumor microenvironment.
Design a thermosensitive gel formulation comprising an outer gel layer and an inner gel layer, wherein the outer gel layer encapsulates the inner gel layer, the outer gel layer contains a glutaminase inhibitor and a photosensitizer, and the inner gel layer contains an immune checkpoint inhibitor. Drug release is controlled by photothermal signals, first releasing the glutaminase inhibitor to regulate metabolic state, and then releasing the immune checkpoint inhibitor to activate T cell immune response.
By regulating the metabolic state of the tumor microenvironment, immunosuppression can be alleviated, the effect of anti-tumor immunotherapy can be enhanced, and efficient tumor killing can be achieved.